AB Science Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1.17	1.07	0.97	0.96	1.61
Revenue Growth (YoY)	9.52%	10.51%	1.25%	-40.39%	1.52%
Cost of Revenue	0.2	-0.18	0.38	0.03	0.11
Gross Profit	0.98	1.25	0.59	0.93	1.5
Selling, General & Admin	2.43	3.4	3.54	3.52	4.07
Research & Development	-2.09	3.94	10.48	13.35	11.23
Operating Expenses	0.34	7.33	14.02	16.87	15.3
Operating Income	0.64	-6.08	-13.43	-15.94	-13.81
Interest Expense	-3.42	-1.12	-1.53	-0.82	-0.02
Interest & Investment Income	-	0.2	0.22	-	-
Currency Exchange Gain (Loss)	-	-0.07	0.42	0.13	-0.02
Other Non Operating Income (Expenses)	1.23	-0.76	2.33	3.02	-0.58
Pretax Income	-1.56	-7.83	-11.99	-13.61	-14.43
Income Tax Expense	-	-	-	0	0.04
Net Income	-1.56	-7.83	-11.99	-13.62	-14.46
Net Income to Common	-1.56	-7.83	-11.99	-13.62	-14.46
Shares Outstanding (Basic)	52	53	50	47	48
Shares Outstanding (Diluted)	52	53	50	47	48
Shares Change (YoY)	-2.58%	7.27%	5.36%	-0.80%	7.45%
EPS (Basic)	-0.03	-0.15	-0.24	-0.29	-0.30
EPS (Diluted)	-0.03	-0.15	-0.24	-0.29	-0.30
Free Cash Flow	-	0.37	-17.22	-18.12	-17.74
Free Cash Flow Per Share	-	0.01	-0.35	-0.38	-0.37
Gross Margin	83.30%	116.42%	60.51%	96.76%	93.09%
Operating Margin	54.43%	-567.44%	-1384.43%	-1663.67%	-859.24%
Profit Margin	-132.62%	-730.50%	-1235.57%	-1421.19%	-900.00%
Free Cash Flow Margin	-	34.52%	-1774.84%	-1890.92%	-1104.05%
EBITDA	1.03	-5.69	-12.8	-15.53	-13.32
EBITDA Margin	87.99%	-	-	-	-
D&A For EBITDA	0.39	0.39	0.63	0.41	0.49
EBIT	0.64	-6.08	-13.43	-15.94	-13.81
EBIT Margin	54.43%	-	-	-	-
Revenue as Reported	-	1.07	0.97	0.96	1.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.